Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Optimal sequencing of the first- and second-line target therapies in metastatic renal cell carcinoma: based on nationally representative data analysis from the Korean National Health Insurance System

Fig. 5

Kaplan–Meier analysis of overall survival stratified by sequencing for patients after age, sex, and CCI matching. A SUN–AXI versus PAZ–AXI, B SUN–AXI versus SUN–CAB, C SUN–AXI versus PAZ–CAB, D PAZ–AXI versus SUN–CAB, E PAZ–AXI versus PAZ–CAB, and F SUN–CAB versus PAZ–CAB

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us